Informações:
Falhas:
ID
25780
Descrição
Direct Factor Xa Inhibitor YM150 for Prevention of Stroke in Subjects With Non-Valvular Atrial Fibrillation; ODM derived from: https://clinicaltrials.gov/show/NCT00448214
Link
https://clinicaltrials.gov/show/NCT00448214
Palavras-chave
Versões (1)
- 19/09/2017 19/09/2017 -
Transferido a
19 de setembro de 2017
DOI
Para um pedido faça login.
Licença
Creative Commons BY 4.0
Comentários do modelo :
Aqui pode comentar o modelo. Pode comentá-lo especificamente através dos balões de texto nos grupos de itens e itens.
Comentários do grupo de itens para :
Comentários do item para :
Para descarregar formulários, precisa de ter uma sessão iniciada. Por favor faça login ou registe-se gratuitamente.
Eligibility Atrial Fibrillation NCT00448214
Eligibility Atrial Fibrillation NCT00448214
- StudyEvent: Eligibility
Similar models
Eligibility Atrial Fibrillation NCT00448214
- StudyEvent: Eligibility
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de dados
Alias
Criteria Fulfill
Item
subjects are eligible for the study if all of the following apply:
boolean
C0243161 (UMLS CUI [1,1])
C1550543 (UMLS CUI [1,2])
C1550543 (UMLS CUI [1,2])
Paroxysmal atrial fibrillation | Permanent atrial fibrillation | Persistent atrial fibrillation | Heart valve disease Absent
Item
subject has paroxysmal permanent or persistent nvaf
boolean
C0235480 (UMLS CUI [1])
C2586056 (UMLS CUI [2])
C2585653 (UMLS CUI [3])
C0018824 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
C2586056 (UMLS CUI [2])
C2585653 (UMLS CUI [3])
C0018824 (UMLS CUI [4,1])
C0332197 (UMLS CUI [4,2])
International Normalized Ratio | Activated Partial Thromboplastin Time measurement
Item
subject has inr of 2.0 or below and an aptt ≤ 1.5 times the upper limit of normal at the baseline visit.
boolean
C0525032 (UMLS CUI [1])
C0030605 (UMLS CUI [2])
C0030605 (UMLS CUI [2])
Age Legal Minimum
Item
legal minimum age requirement (country-specific).
boolean
C0001779 (UMLS CUI [1,1])
C1301860 (UMLS CUI [1,2])
C1524031 (UMLS CUI [1,3])
C1301860 (UMLS CUI [1,2])
C1524031 (UMLS CUI [1,3])
Informed Consent
Item
written informed consent has been obtained.
boolean
C0021430 (UMLS CUI [1])
Heart valve disease
Item
history of heart valve disorders
boolean
C0018824 (UMLS CUI [1])
Rheumatic Fever
Item
history of rheumatic fever.
boolean
C0035436 (UMLS CUI [1])
Cerebrovascular accident | EMBOLISM, SYSTEMIC ARTERIAL | Transient Ischemic Attack
Item
history of stroke and/or systemic embolism (including tia).
boolean
C0038454 (UMLS CUI [1])
C0149876 (UMLS CUI [2])
C0007787 (UMLS CUI [3])
C0149876 (UMLS CUI [2])
C0007787 (UMLS CUI [3])
Acute Coronary Syndrome
Item
history of acute coronary syndrome (acs).
boolean
C0948089 (UMLS CUI [1])
Indication Warfarin | Exception Atrial Fibrillation Without Heart valve disease
Item
indication for warfarin other than nvaf.
boolean
C3146298 (UMLS CUI [1,1])
C0043031 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0004238 (UMLS CUI [2,2])
C0332288 (UMLS CUI [2,3])
C0018824 (UMLS CUI [2,4])
C0043031 (UMLS CUI [1,2])
C1705847 (UMLS CUI [2,1])
C0004238 (UMLS CUI [2,2])
C0332288 (UMLS CUI [2,3])
C0018824 (UMLS CUI [2,4])
Hemorrhagic Disorders | Blood Coagulation Disorders
Item
known hemorrhagic disorder and/or coagulation disorder.
boolean
C0019087 (UMLS CUI [1])
C0005779 (UMLS CUI [2])
C0005779 (UMLS CUI [2])
Hemorrhage | Condition Associated with Bleeding Risk
Item
active bleeding or any condition associated with increased risk of bleeding.
boolean
C0019080 (UMLS CUI [1])
C0348080 (UMLS CUI [2,1])
C0332281 (UMLS CUI [2,2])
C3251812 (UMLS CUI [2,3])
C0348080 (UMLS CUI [2,1])
C0332281 (UMLS CUI [2,2])
C3251812 (UMLS CUI [2,3])